Beam Therapeutics Announces CFO Terry-Ann Burrell’s Resignation
Company Announcements

Beam Therapeutics Announces CFO Terry-Ann Burrell’s Resignation

An announcement from Beam Therapeutics (BEAM) is now available.

Terry-Ann Burrell has decided to step down as the Chief Financial Officer and Treasurer of Beam Therapeutics Inc., effective August 9, 2024, to explore new ventures. Following her resignation, CEO John Evans will take over her financial responsibilities while maintaining his current role as CEO. This change in the company’s financial leadership was announced recently, signaling a shift in Beam Therapeutics’ executive team.

See more insights into BEAM stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyBeam Therapeutics price target lowered to $31 from $33 at Barclays
TheFlyBeam Therapeutics reports Q2 EPS ($1.11), consensus ($1.13)
GlobeNewswireBeam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!